SGCG and idiopathic pulmonary fibrosis: These markers include PRO-C3 and PRO-C6, biomarkers of type III and VI collagen synthesis, respectively, which have been found to be increased in blood from progressing IPF patients as compared to stable IPF patients in the PROFILE (Prospective Observation of Fibrosis in the Lung Clinical Endpoints) study [35].